A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2002
08/29/2002	WO2002000227A3 Use of lanthanum compounds for the treatment of bone diseases
08/29/2002	WO2001096547A3 Human kinases
08/29/2002	WO2001085092A3 Antidiarrheal cannabinoid cb-1 receptor antagonist
08/29/2002	WO2001037785A9 Novel methods and compositions involving opioids and antagonists thereof
08/29/2002	WO2001017364A9 Food product and process for manufacturing same
08/29/2002	WO2001012584A3 Pharmaceutical compounds
08/29/2002	WO2000068188A9 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
08/29/2002	WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/29/2002	WO2000066737A9 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY
08/29/2002	WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof
08/29/2002	WO2000061788A3 Poly(dipeptide) as a drug carrier
08/29/2002	WO2000061606A9 Novel human voltage-gated potassium channel
08/29/2002	WO2000059515A9 Immunomodulating polymers
08/29/2002	WO2000056866A9 Akt-3 nucleic acids, polypeptides, and uses thereof
08/29/2002	US20020120948 Modulating gene expression by regulation of cell proliferation; regulated transgene expression in lymphocytes by selective increase in the number of lymphocytes upon exposure to an antigen
08/29/2002	US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence
08/29/2002	US20020120147 Micronized torsemide
08/29/2002	US20020120103 17 human secreted proteins
08/29/2002	US20020120014 Rhinologically active substances
08/29/2002	US20020119994 LFA-1 Antagonist compounds
08/29/2002	US20020119988 Modulators of TNF-alpha signaling
08/29/2002	US20020119977 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent
08/29/2002	US20020119976 Tetracyclic derivatives, process of preparation and use
08/29/2002	US20020119975 Autoimmune disease; antiinflammatory agents; antiallergens; antiproliferative agents; anticancer agents
08/29/2002	US20020119973 Antiinflammatory agents
08/29/2002	US20020119967 Autoimmune diseases; administering phosphodiesterases inhibitor
08/29/2002	US20020119964 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase
08/29/2002	US20020119961 Bridged piperazine derivatives
08/29/2002	US20020119956 Using thalidomine
08/29/2002	US20020119519 Nucleotide sequences coding preferential polyeptide for use in the treatment of cancer, kidney and respiratory disorders
08/29/2002	US20020119202 For therapy of cancer and other angiogenic-dependent diseases
08/29/2002	US20020119186 Establishing a drug depot in tissues under the user's skin surface by applying a transdermal drug delivery system on a user's skin; allowing transdermal drug delivery system to be applied on skin area without heating; placing heating source
08/29/2002	US20020119164 Use of agaricus blazei murill to prevent or treat skin and other disorders
08/29/2002	US20020119104 Treatment of mucositis
08/29/2002	DE10108307A1 Substituierte Propan-1,3-diamin-Derivate Substituted propane-1,3-diamine derivatives
08/29/2002	DE10107683A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical
08/29/2002	CA2453078A1 2-thio-substituted imidazole derivatives and their use in pharmacy
08/29/2002	CA2438685A1 Tryptase inhibitors
08/29/2002	CA2438682A1 Antibodies that bind both bcma and taci
08/29/2002	CA2438369A1 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
08/29/2002	CA2438312A1 Anthrone derivatives and their use as jnk inhibitors
08/29/2002	CA2438235A1 Neurotransmission-associated proteins
08/29/2002	CA2437977A1 Phenethanolamine derivatives for treatment of respiratory diseases
08/29/2002	CA2437242A1 Tramadol-based medicament
08/29/2002	CA2437168A1 Retinoid hepatitis therapy
08/29/2002	CA2436399A1 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
08/29/2002	CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/28/2002	EP1234834A1 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient
08/28/2002	EP1234818A1 Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same
08/28/2002	EP1234815A2 Crystalline choline ascorbate
08/28/2002	EP1234576A1 Us0027324for eating disorders
08/28/2002	EP1234553A1 Bioartificial device
08/28/2002	EP1234030A2 18 human secreted proteins
08/28/2002	EP1234025A1 Human enzymes of the metalloprotease family
08/28/2002	EP1234024A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus
08/28/2002	EP1233983A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies
08/28/2002	EP1233981A1 G-protein coupled receptor
08/28/2002	EP1233975A1 29 human secreted proteins
08/28/2002	EP1233965A1 Isoquinoline and quinazoline derivatives for the treatment of cns disorders
08/28/2002	EP1233964A1 New use and novel n-azabicyclo-amide derivatives
08/28/2002	EP1233963A2 Novel sulfonyl oxazole amines
08/28/2002	EP1233960A2 Polymorphic salt of an anti-migraine drug
08/28/2002	EP1233959A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
08/28/2002	EP1233951A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
08/28/2002	EP1233950A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
08/28/2002	EP1233942A2 Treatment of inflammatory bowel disease with vitamin d compounds
08/28/2002	EP1233790A2 A33 antigen specific immunoglobulin products in cancer therapy
08/28/2002	EP1233786A2 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance
08/28/2002	EP1233781A1 Assays and therapies for latent viral infection
08/28/2002	EP1233777A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies
08/28/2002	EP1233774A1 Urotensin-ii analogs
08/28/2002	EP1233771A1 Protease inhibitors
08/28/2002	EP1233767A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
08/28/2002	EP1233765A1 TREATMENT OF EOSINOPHIL ASSOCIATED PATHOLOGIES BY MODULATING PKC-$g(d) ACTIVITY
08/28/2002	EP1233756A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
08/28/2002	EP1140898B1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
08/28/2002	EP1123092B1 Fumaric acid microtablets
08/28/2002	EP1082114B1 Hydroxyomeprazole compositions and uses
08/28/2002	EP1073653B1 Novel 2-heterocyclically substituted dihydropyrimidines
08/28/2002	EP1071702B1 Fatty acid derivatives of bile acids and bile acid derivatives
08/28/2002	EP0897386B1 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
08/28/2002	EP0892804B1 Isoxazolidine derivatives
08/28/2002	EP0856001B1 Pyrimidine derivatives as 5ht2c receptor antagonists
08/28/2002	CN1366524A Sulfonamide derivative as matrix metalloproteinase inhibitor
08/28/2002	CN1366521A Substituted 1-aza-2-imino heterocycles and their use as nicotinic acetylcholine receptors activators
08/28/2002	CN1366520A Medicine
08/28/2002	CN1366518A Biphenyl butyric acid derivative as matrix metalloproteinase inhibitor
08/28/2002	CN1366461A Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as active ingredient
08/28/2002	CN1366038A Bioregulator for reconfiguring human immune function and its preparing process
08/28/2002	CN1365823A Active full-component wheat spear extract and its microcapsule and preparing process
08/28/2002	CN1365822A 'Shugan Lidan' capsule and its preparing process
08/28/2002	CN1365821A Medicine 'Huwei Dan' for treating injury and gastroenteropathy
08/28/2002	CN1365820A Enema
08/28/2002	CN1365818A Antimycotic antidiarrheal
08/28/2002	CN1365814A Nano liver-protecting medicine and its preparing process
08/28/2002	CN1365813A Nano human placenta medicine and its preparing process
08/28/2002	CN1365810A Nano medicine 'Guishao Dihuang' and its preparing process
08/28/2002	CN1365808A Nano medicine 'Guilu Bushen' and its preparing process
08/28/2002	CN1365806A Nano medicine 'Chunyang Zhengqi' and its preparing process
08/28/2002	CN1365805A Nano medicine 'Chenxiang Huaqi' and its preparing process

1 ... 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 ... 1258